Stock ADPT ADAPTIVE BIOTECHNOLOGIES CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

All News Adaptive Biotechnologies Corporation

Equities

ADPT

US00650F1093

Market Closed - Nasdaq
Other stock markets
 21:00:00 26/04/2024 BST 		5-day change 1st Jan Change
2.6 USD -0.38% Intraday chart for Adaptive Biotechnologies Corporation +8.33% -46.94%
04-05 Adaptive Biotechnologies Corporation Announces Preliminary Unaudited Revenue Results for the First Quarter Ended March 31, 2024 CI
04-03 Adaptive Biotechnologies Corporation Announces CFO Changes CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
GL
Adaptive Biotechnologies Corporation Announces Preliminary Unaudited Revenue Results for the First Quarter Ended March 31, 2024
CI
Adaptive Biotechnologies Corporation Announces CFO Changes
CI
Adaptive Biotechnologies Reports Preliminary Q1 Revenue, Appoints Kyle Piskel as CFO
MT
Transcript : Adaptive Biotechnologies Corporation - Special Call
Adaptive Biotechnologies Provides Strategic Review Update and Announces Preliminary First Quarter 2024 Revenue
GL
Adaptive Biotechnologies Corporation Provides Revenue Guidance for the First Quarter Ended March 31, 2024
CI
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
GL
Adaptive Biotechnologies to Hold a Business Update Conference Call and Webcast on April 2, 2024
AQ
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference
GL
Adaptive Biotechnologies to Present at the TD Cowen 44th Annual Healthcare Conference
AQ
JPMorgan Adjusts Price Target on Adaptive Biotechnologies to $8 From $11, Maintains Overweight Rating
MT
Adaptive Biotechnologies' Q4 Loss Widens; Revenue Declines; Shares Down
MT
Adaptive Biotechnologies: Q4 Earnings Snapshot
AQ
Transcript : Adaptive Biotechnologies Corporation, Q4 2023 Earnings Call, Feb 14, 2024
Earnings Flash (ADPT) ADAPTIVE BIOTECHNOLOGIES Reports Q4 Revenue $45.8M, vs. Street Est of $48.5M
MT
Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2023 Financial Results
GL
Adaptive Biotechnologies Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
CI
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024
GL
Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 14, 2024
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ADPT Stock
  4. News Adaptive Biotechnologies Corporation